Congenital corneal opacification
There is a groundswell of desire to re-examine the current nomenclature for congenital or neonatal corneal opacities
Ken Nischal MD addressing delegates at the 4th World Congress of Paediatric Ophthalmology and Strabismus in Hyderabad, India
There is a groundswell of desire to re-examine the current nomenclature for congenital or neonatal corneal opacities, according to key opinion leaders attending the 4th World Congress of Paediatric Ophthalmology and Strabismus in Hyderabad, India.
Aimed at reaching a consensus towards this, a session titled “Congenital Corneal Opacification Nomenclature, Time for a Change” was chaired by Ken Nischal MD.
Following an audience vote, it was determined that it was time for a change in the nomenclature. Of all the terms discussed, there appeared to be consensus that “sclerocornea” was a misleading term both clinically and histologically.
The cornea in “sclerocornea’ is not scleral tissue but abnormal corneal tissue.
Through WSPOS and other key societies, all interested individuals and societies were encouraged to express an interest in forming a working group. Led by Drs. Serafino, Nucci and Nischal, a Delphi consensus process was planned to attain common ground and reach a consensus for a new nomenclature system for congenital or neonatal corneal opacities.
The Delphi system relies on a structured communication system between a panel of experts who answer questionnaires in rounds, after each of which a summary is provided and experts can revise their previous stand in light of replies by other participant experts.
In this case, electronic questionnaires are planned followed eventually by a face to face meeting of as many participants of the electronic questionnaire as possible.